Literature DB >> 21170918

Generalized pairwise comparisons of prioritized outcomes in the two-sample problem.

Marc Buyse1.   

Abstract

This paper extends the idea behind the U-statistic of the Wilcoxon-Mann-Whitney test to perform generalized pairwise comparisons between two groups of observations. The observations are outcomes captured by a single variable, possibly repeatedly measured, or by several variables of any type (e.g. discrete, continuous, time to event). When several outcomes are considered, they must be prioritized. We show that generalized pairwise comparisons extend well-known non-parametric tests, and illustrate their interest using data from two randomized clinical trials. We also show that they lead to a general measure of the difference between the groups called the 'proportion in favor of treatment', denoted Δ, which is related to traditional measures of treatment effect for a single variable.
Copyright © 2010 John Wiley & Sons, Ltd.

Mesh:

Substances:

Year:  2010        PMID: 21170918     DOI: 10.1002/sim.3923

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  34 in total

1.  Large sample inference for a win ratio analysis of a composite outcome based on prioritized components.

Authors:  Ionut Bebu; John M Lachin
Journal:  Biostatistics       Date:  2015-09-08       Impact factor: 5.899

2.  The inverse-probability-of-censoring weighting (IPCW) adjusted win ratio statistic: an unbiased estimator in the presence of independent censoring.

Authors:  Gaohong Dong; Lu Mao; Bo Huang; Margaret Gamalo-Siebers; Jiuzhou Wang; GuangLei Yu; David C Hoaglin
Journal:  J Biopharm Stat       Date:  2020-06-17       Impact factor: 1.051

3.  Properties of composite time to first event versus joint marginal analyses of multiple outcomes.

Authors:  Ionut Bebu; John M Lachin
Journal:  Stat Med       Date:  2018-06-28       Impact factor: 2.373

4.  Opportunities and challenges of clinical trials in cardiology using composite primary endpoints.

Authors:  Geraldine Rauch; Bernhard Rauch; Svenja Schüler; Meinhard Kieser
Journal:  World J Cardiol       Date:  2015-01-26

5.  Validation of reference and identity-defining genes in human mesenchymal stem cells cultured under unrelated fetal bovine serum batches for basic science and clinical application.

Authors:  Federica Banfi; Alessandra Colombini; Carlotta Perucca Orfei; Valentina Parazzi; Enrico Ragni
Journal:  Stem Cell Rev Rep       Date:  2018-12       Impact factor: 5.739

Review 6.  Biomarker validation: common data analysis concerns.

Authors:  Joe E Ensor
Journal:  Oncologist       Date:  2014-07-07

7.  Weighted win loss approach for analyzing prioritized outcomes.

Authors:  Xiaodong Luo; Junshan Qiu; Steven Bai; Hong Tian
Journal:  Stat Med       Date:  2017-03-26       Impact factor: 2.373

8.  Assessing Long-Term Survival Benefits of Immune Checkpoint Inhibitors Using the Net Survival Benefit.

Authors:  Julien Péron; Alexandre Lambert; Stephane Munier; Brice Ozenne; Joris Giai; Pascal Roy; Stéphane Dalle; Abigirl Machingura; Delphine Maucort-Boulch; Marc Buyse
Journal:  J Natl Cancer Inst       Date:  2019-11-01       Impact factor: 13.506

9.  Global rank tests for multiple, possibly censored, outcomes.

Authors:  Ritesh Ramchandani; David A Schoenfeld; Dianne M Finkelstein
Journal:  Biometrics       Date:  2016-01-26       Impact factor: 2.571

10.  Quantifying treatment effects using the personalized chance of longer survival.

Authors:  Ying-Qi Zhao; Mary W Redman; Michael L LeBlanc
Journal:  Stat Med       Date:  2019-09-09       Impact factor: 2.373

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.